Georgia State Menu
Georgia State Menu

Main navigation

Georgia Health Policy Center

Andrew Young School of Policy Studies

Main navigation

Provider Training Video Series

Provider Training Video Series

Provider Training Video Series

Click the titles below for learning objectives, accreditation information, and instructions for completing the individual modules.

Introduction

Introduction (WD2833)

To watch the course video, click here 
To register for continuing education credit, click here

For other modules in this series, click here.

 

PROGRAM DESCRIPTION: Activities are designed to increase knowledge and change competency of transfusion practices and strategies for individuals with hemoglobin disorders.  Content is derived from actual peer-reviewed publications.

OBJECTIVES: At the conclusion of the session, the participant will be able to:

  1. Describe the optimal hemoglobin level when transfusing a sickle cell patient
  2. List common reasons for transfusing individuals with sickle cell disease
  3. Recognize common complications of transfusion in sickle cell disease
  4. Locate current evidence-based recommendations for transfusion in sickle cell disease

FACULTY: James Eckman, M.D., professor emeritus of hematology and oncology, Emory University School of Medicine; founding director of the comprehensive sickle cell center at Grady Health System

ORIGINATION DATE: August 25, 2017
EXPIRATION DATE: August 25, 2019
URL: https://vimeo.com/228372214
HARDWARE/SOFTWARE: Computer hardware, Internet connection; browser
MATERIALS: None
TARGET AUDIENCE: DOs, MDs, NPs, PAs
PREREQUISITES: n/a
FORMAT: Web-on-demand streaming
CONTACT: Mary Hulihan, 404-498-6724

CME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Centers for Disease Control and Prevention and Georgia State University. The Centers for Disease Control and Prevention is accredited (by the ACCME) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Centers for Disease Control and Prevention designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education (CNE) by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 0.3 contact hours.

CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. 

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

The Centers for Disease Control and Prevention, Emory University School of Medicine, and Georgia State University are jointly providing the CNE for this activity.

CDC did not accept commercial support for this continuing education activity.

To receive continuing education credit: 

  1. Complete the activity at https://vimeo.com/228372214
  2. Complete the evaluation at https://tceols.cdc.gov/
  3. Pass the posttest at 75% at https://tceols.cdc.gov/

FEES:  There are no fees charged for CDC’s continuing education activities.

Case 1: Use of Blood Transfusion during Acute Illness

To watch the course video, click here
To register for continuing education credit, click here

For other modules in this series, click here.

 

PROGRAM DESCRIPTION: Activities are designed to increase knowledge and change competency of transfusion practices and strategies for individuals with hemoglobin disorders.  Content is derived from actual peer-reviewed publications.

OBJECTIVES: At the conclusion of the session, the participant will be able to:

  1. Recognize indications for red blood cell transfusion during acute illness in individuals with sickle cell disease
  2. Describe appropriate selection of blood products for transfusion during acute illness in individuals with SCD
  3. Identify management strategies for acute splenic sequestration in SCD
  4. Describe indications for RBC transfusion prior to elective surgical procedures in SCD

FACULTY: Peter A. Lane, M.D., Professor of Pediatrics, Emory University School of Medicine; Director, Sickle Cell Disease Program, Children’s Healthcare of Atlanta

ORIGINATION DATE: October 16, 2017
EXPIRATION DATE: October 16, 2019        
URL: https://vimeo.com/230451617
HARDWARE/SOFTWARE: Computer hardware; Internet connection; browser
MATERIALS: None
TARGET AUDIENCE: DOs, MDs, NPs, PAs
PREREQUISITES: n/a
FORMAT: Web-on-demand streaming
CONTACT: Mary Hulihan, 404-498-6724

CME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and Georgia State University. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Centers for Disease Control and Prevention designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 0.5 contact hours.

CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. 

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

The Centers for Disease Control and Prevention, Emory University School of Medicine, and Georgia State University are jointly providing the CNE for this activity.

CDC did not accept commercial support for this continuing education activity.

To receive continuing education credit:

  1. Complete the activity at https://vimeo.com/230451617
  2. Complete the evaluation at https://tceols.cdc.gov/
  3. Pass the posttest at 75% at https://tceols.cdc.gov/

FEES: There are no fees charged for CDC’s continuing education activities.

Case 2: Delayed Hemolytic Transfusion Reactions

To watch the course video, click here
To register for continuing education credit, click here

For other modules in this series, click here.

 

PROGRAM DESCRIPTION: Activities are designed to increase knowledge and change competency of transfusion practices and strategies for individuals with hemoglobin disorders.  Content is derived from actual peer-reviewed publications.

OBJECTIVES: At the conclusion of the session, the participant will be able to:

  1. Describe practice recommendations for transfusion in sickle cell disease patients with acute chest syndrome
  2. Explain the pathophysiology of delayed hemolytic transfusion reactions and hyperhemolysis
  3. List techniques for evaluating alloantibodies and DHTR
  4. Explain the assessment and management of DHTR

FACULTY: Ross Fasano, MD, Assistant Professor in the Department of Laboratory Medicine, Emory University School of Medicine; Director of Apheresis and Pediatric Hematologist, Children’s Healthcare of Atlanta

ORIGINATION DATE: October 16, 2017
EXPIRATION DATE: October 16, 2019        
URL: https://vimeo.com/230453936
HARDWARE/SOFTWARE: Computer hardware; Internet connection; browser
MATERIALS: None
TARGET AUDIENCE: DOs, MDs, NPs, PAs
PREREQUISITES: n/a
FORMAT: Web-on-demand streaming
CONTACT INFORMATION: Mary Hulihan, 404-498-6724

CME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and Georgia State University. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Centers for Disease Control and Prevention designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 0.4 contact hours.

CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. 

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

The Centers for Disease Control and Prevention, Emory University School of Medicine, and Georgia State University are jointly providing the CNE for this activity.

CDC did not accept commercial support for this continuing education activity.

To receive continuing education credit:

  1. Complete the activity at https://vimeo.com/230453936
  2. Complete the evaluation at https://tceols.cdc.gov/
  3. Pass the posttest at 75% at https://tceols.cdc.gov/

FEES: There are no fees charged for CDC’s continuing education activities.

Case 3: Management of Chronic Transfusion

To watch the course video, click here
To register for continuing education credit, click here

For other modules in this series, click here.

 

PROGRAM DESCRIPTION: Activities are designed to increase knowledge and change competency of transfusion practices and strategies for individuals with hemoglobin disorders.  Content is derived from actual peer-reviewed publications.

OBJECTIVES: At the conclusion of the session, the participant will be able to:

  1. Describe the role of chronic transfusion in preventing and managing certain complications of sickle cell disease
  2. Describe prevention and management of alloimmunization in individuals on chronic transfusion
  3. Describe the importance of iron overload in chronically transfused patients with sickle cell disease
  4. Describe the management of iron overload in patients on chronic transfusion

FACULTY: James Eckman, MD, Professor Emeritus of Hematology and Oncology, Emory University School of Medicine; Founding Director of the Comprehensive Sickle Cell Center, Grady Health System

ORIGINATION DATE: October 16, 2017
EXPIRATION DATE: October 16, 2019        
URL: https://vimeo.com/230461514
HARDWARE/SOFTWARE: Computer hardware; Internet connection; browser
MATERIALS: None
TARGET AUDIENCE: DOs, MDs, NPs, PAs
PREREQUISITES: n/a
FORMAT: Web-on-demand streaming
CONTACT INFORMATION: Mary Hulihan, 404-498-6724

CME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and Georgia State University. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Centers for Disease Control and Prevention designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 0.5 contact hours.

CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. 

Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Eckman’s discussion on Deferiprone in the treatment of iron overload in sickle cell disease. Deferiprone is approved for treatment of iron overload in thalassemia, but not for sickle cell disease. A five-year study in Italy documents similar safety and effectiveness to Deferoxamime in sickle cell disease. (Blood Cells Molecules & Diseases. 53(4):265-71, 2014 Dec.)

The Centers for Disease Control and Prevention, Emory University School of Medicine, and Georgia State University are jointly providing the CNE for this activity.

CDC did not accept commercial support for this continuing education activity.

To receive continuing education credit:

  1. Complete the activity at https://vimeo.com/230461514
  2. Complete the evaluation at https://tceols.cdc.gov/
  3. Pass the posttest at 75% at https://tceols.cdc.gov/

FEES: There are no fees charged for CDC’s continuing education activities.